• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[针对两种或更多心血管危险因素服用药物的受试者的生活方式。TAR-RISC研究]

[Lifestyles of subjects who take drugs for two or more cardiovascular risk factors. TAR-RISC Study].

作者信息

Margalef Josep Carles Llop, Anadón Silvia Hernández, Ibars Josep Bítria, Josa Albert, Crespo José María, Romero Ferran Bejarano, Llor Carles

机构信息

Región Sanitaria de Tarragona, España.

出版信息

Aten Primaria. 2011 May;43(5):229-35. doi: 10.1016/j.aprim.2009.11.011. Epub 2010 May 20.

DOI:10.1016/j.aprim.2009.11.011
PMID:20488586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7024922/
Abstract

OBJECTIVE

To describe the basic characteristics and lifestyles of the population of a Health Region, on medication for two or more cardiovascular risk factors.

DESIGN

Cross-sectional descriptive study.

SETTING

Tarragona Primary Care.

PARTICIPANTS

The subjects, less than 65 years-old, were identified by the dispensing data of hypertensive, glucose-lowering and lipid-lowering pharmaceutical drugs.

MAIN MEASUREMENTS AND RESULTS

Specific structured questionnaires were designed for each drugs group, and the information was gathered by telephone. Age, sex, sedentarism, alcohol and tobacco habits, diet and body mass index were analysed. A total of 1201 patients, with a mean age of 58.9±7.6 years, were interviewed. There were 54.2% males. A total of 636 (53.0%) subjects took anti-hypertensive and cholesterol lowering drugs, 212 (17.7%) anti-hypertensive and glucose lowering drugs, and 128 (10.8%) cholesterol lowering and glucose lowering drugs, and 225 (18.7%) patients took drugs from the three groups. There were 19.2% active smokers, 5.7% stated excessive alcohol consumption, 266 (22.2%) stated that they did not follow any diet, and 15% were sedentary or did a minimum of physical activity. The mean body mass index was 29.9±4.9 kg/m(2), being highest among the subjects who took anti-hypertensive and glucose lowering drugs (P<0.001), and 44.2% were obese.

CONCLUSIONS

Approximately one fifth of the subjects who took at least 2 pharmacological groups was an active smoker, one quarter of the total did not follow a diet, half were obese and two-thirds did little or no physical activity. These results show low compliance to hygienic-dietetic measures by patients with an increased cardiovascular risk.

摘要

目的

描述某健康区域内正在服用治疗两种或更多心血管危险因素药物的人群的基本特征和生活方式。

设计

横断面描述性研究。

地点

塔拉戈纳初级保健机构。

参与者

通过降压药、降糖药和降脂药的配药数据确定年龄小于65岁的受试者。

主要测量指标与结果

为每个药物组设计了特定的结构化问卷,并通过电话收集信息。分析了年龄、性别、久坐情况、饮酒和吸烟习惯、饮食及体重指数。共访谈了1201名患者,平均年龄为58.9±7.6岁,其中男性占54.2%。共有636名(53.0%)受试者服用降压药和降胆固醇药,212名(17.7%)服用降压药和降糖药,128名(10.8%)服用降胆固醇药和降糖药,225名(18.7%)患者服用这三组药物。有19.2%的人是现吸烟者,5.7%的人表示饮酒过量,266名(22.2%)表示他们没有遵循任何饮食规律,15%的人久坐不动或极少进行体育活动。平均体重指数为29.9±4.9kg/m²,在服用降压药和降糖药的受试者中最高(P<0.001),44.2%的人肥胖。

结论

服用至少两类药物的受试者中约五分之一是现吸烟者,四分之一的人未遵循饮食规律,一半的人肥胖,三分之二的人极少或不进行体育活动。这些结果表明心血管风险增加的患者对卫生饮食措施的依从性较低。

相似文献

1
[Lifestyles of subjects who take drugs for two or more cardiovascular risk factors. TAR-RISC Study].[针对两种或更多心血管危险因素服用药物的受试者的生活方式。TAR-RISC研究]
Aten Primaria. 2011 May;43(5):229-35. doi: 10.1016/j.aprim.2009.11.011. Epub 2010 May 20.
2
A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.一个用于葡萄糖处理受损(IGH)的初级保健登记册:对心血管代谢特征的影响。
Prim Care Diabetes. 2012 Oct;6(3):213-9. doi: 10.1016/j.pcd.2012.02.002. Epub 2012 May 4.
3
Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.在阿卜杜勒阿齐兹国王大学医院的普通诊所就诊的高危人群中的心血管危险因素:一项横断面研究。
BMC Cardiovasc Disord. 2019 Nov 27;19(1):268. doi: 10.1186/s12872-019-1261-6.
4
General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark.丹麦 ADDITION 研究:基层医生对血脂异常管理指南的遵循情况。
Scand J Prim Health Care. 2010 Mar;28(1):47-54. doi: 10.3109/02813430903335216.
5
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.大型初级保健队列中进行心血管风险评估后启动和维持心血管药物治疗:PREDICT CVD-16研究
Eur J Prev Cardiol. 2014 Feb;21(2):192-202. doi: 10.1177/2047487312462150. Epub 2012 Oct 2.
6
Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.奥利司他起始治疗对心血管治疗使用的影响:一项基于人群的 6 年队列研究。
Eur J Prev Cardiol. 2012 Jun;19(3):484-9. doi: 10.1177/1741826711406058. Epub 2011 Apr 4.
7
Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker' health study (Spain).心血管预防治疗的联合处方模式:西班牙阿拉贡工人健康研究中的一项横断面研究。
BMJ Open. 2019 Apr 14;9(4):e023571. doi: 10.1136/bmjopen-2018-023571.
8
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.2010 年法国的降压、降糖和降脂治疗频率。
Arch Cardiovasc Dis. 2013 May;106(5):274-86. doi: 10.1016/j.acvd.2013.02.005. Epub 2013 May 21.
9
Clustering of lifestyle characteristics and their association with cardio-metabolic health: the Lifestyles and Endothelial Dysfunction (EVIDENT) study.生活方式特征聚类及其与心血管代谢健康的关联:生活方式与内皮功能障碍(EVIDENT)研究
Br J Nutr. 2015 Sep 28;114(6):943-51. doi: 10.1017/S0007114515002500. Epub 2015 Aug 13.
10
Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.联合药物和非药物策略对心血管危险因素的影响:CELL研究的主要结果
J Intern Med. 1996 Jul;240(1):13-22. doi: 10.1046/j.1365-2796.1996.492831000.x.

引用本文的文献

1
Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.在社区药房筛查病前代谢综合征:一项横断面描述性研究。
BMC Public Health. 2014 May 22;14:487. doi: 10.1186/1471-2458-14-487.

本文引用的文献

1
Self-reported smoking in online surveys: prevalence estimate validity and item format effects.在线调查中自我报告的吸烟情况:患病率估计的有效性及项目格式效应
Med Care. 2007 Jul;45(7):691-5. doi: 10.1097/MLR.0b013e3180326145.
2
[Cardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project study].[血压未控制的高血压患者的心血管风险状况。Control-Project研究]
Med Clin (Barc). 2007 Jan 27;128(3):86-91. doi: 10.1016/s0025-7753(07)72498-3.
3
The validity of obesity based on self-reported weight and height: Implications for population studies.基于自我报告的体重和身高得出的肥胖症有效性:对人群研究的启示。
Obesity (Silver Spring). 2007 Jan;15(1):197-208. doi: 10.1038/oby.2007.536.
4
Reported versus measured body weight and height of 4-year-old children and the prevalence of overweight.4岁儿童报告的与测量的体重、身高及超重患病率
Eur J Public Health. 2007 Aug;17(4):369-74. doi: 10.1093/eurpub/ckl253. Epub 2006 Nov 23.
5
[Cardiovascular risk in diabetes mellitus and hypertension in Spain. The CORONARIA study].
Med Clin (Barc). 2006 Jun 24;127(4):126-32. doi: 10.1157/13090381.
6
[Treatment and control of cardiovascular risk in primary care in Spain. The PREVENCAT study].[西班牙初级保健中心血管风险的治疗与控制。PREVENCAT研究]
Med Clin (Barc). 2006 Feb 18;126(6):201-5. doi: 10.1157/13084868.
7
[PREVENCAT study: control of cardiovascular risk in primary care].
Med Clin (Barc). 2005 Mar 26;124(11):406-10. doi: 10.1157/13072841.
8
[Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project].
Med Clin (Barc). 2005 Jan 22;124(2):44-9. doi: 10.1157/13070450.
9
[Degree of understanding, treatment and control of hypertension, hypercholesterolemia and diabetes mellitus in the general adult population].[普通成年人群中高血压、高胆固醇血症和糖尿病的知晓程度、治疗及控制情况]
Aten Primaria. 2004 Mar 31;33(5):254-60. doi: 10.1016/s0212-6567(04)79411-1.
10
Clinical inertia.临床惰性
Ann Intern Med. 2001 Nov 6;135(9):825-34. doi: 10.7326/0003-4819-135-9-200111060-00012.